CervoMed Statistics
Total Valuation
CervoMed has a market cap or net worth of $148.09 million. The enterprise value is $140.30 million.
| Market Cap | 148.09M |
| Enterprise Value | 140.30M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CervoMed has 6.17 million shares outstanding. The number of shares has increased by 413.65% in one year.
| Shares Outstanding | 6.17M |
| Shares Change (YoY) | +413.65% |
| Shares Change (QoQ) | -29.34% |
| Owned by Insiders (%) | 41.87% |
| Owned by Institutions (%) | 6.43% |
| Float | 1.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.73 |
| Forward PS | 16.69 |
| PB Ratio | 20.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.84, with zero debt.
| Current Ratio | 3.84 |
| Quick Ratio | 3.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.30% and return on invested capital (ROIC) is -105.91%.
| Return on Equity (ROE) | -18.30% |
| Return on Assets (ROA) | -15.50% |
| Return on Capital (ROIC) | -105.91% |
| Revenue Per Employee | $893,109 |
| Profits Per Employee | -$271,484 |
| Employee Count | 8 |
| Asset Turnover | 0.51 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +240.43% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +240.43% |
| 50-Day Moving Average | 18.69 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 57.54 |
| Average Volume (30 Days) | 29,770 |
Short Selling Information
The latest short interest is 20,592, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 20,592 |
| Short Previous Month | 18,504 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 1.12% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, CervoMed had revenue of $7.14 million and -$2.17 million in losses. Loss per share was -$0.82.
| Revenue | 7.14M |
| Gross Profit | 7.14M |
| Operating Income | -7.81M |
| Pretax Income | -2.17M |
| Net Income | -2.17M |
| EBITDA | -2.17M |
| EBIT | -2.17M |
| Loss Per Share | -$0.82 |
Balance Sheet
The company has $7.79 million in cash and no debt, giving a net cash position of $7.79 million or $1.26 per share.
| Cash & Cash Equivalents | 7.79M |
| Total Debt | n/a |
| Net Cash | 7.79M |
| Net Cash Per Share | $1.26 |
| Equity / Book Value | 7.38M |
| Book Value Per Share | 1.20 |
| Working Capital | 7.37M |
Cash Flow
| Operating Cash Flow | -7.45M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.45M |
| FCF Per Share | -$2.80 |
Margins
Gross margin is 100.00%, with operating and profit margins of -109.35% and -30.40%.
| Gross Margin | 100.00% |
| Operating Margin | -109.35% |
| Pretax Margin | -30.40% |
| Profit Margin | -30.40% |
| EBITDA Margin | -30.40% |
| EBIT Margin | -30.40% |
| FCF Margin | -104.27% |
Dividends & Yields
CervoMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -413.65% |
| Shareholder Yield | -413.65% |
| Earnings Yield | -1.47% |
| FCF Yield | -5.03% |
Analyst Forecast
The average price target for CervoMed is $65.00, which is 170.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $65.00 |
| Price Target Difference | 170.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 2:3.
| Last Split Date | Aug 17, 2023 |
| Split Type | Reverse |
| Split Ratio | 2:3 |
Scores
CervoMed has an Altman Z-Score of 27.47 and a Piotroski F-Score of 1.
| Altman Z-Score | 27.47 |
| Piotroski F-Score | 1 |